One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT
- DOI
- 10.3310/wwbf1044
- Published
- 2023-11
- Container
- Health Technology Assessment
- Publisher
- National Institute for Health and Care Research
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3310/wwbf1044,
title = {One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT},
author = {Adrian Murray Brunt and Joanne S Haviland and Duncan A Wheatley and Mark A Sydenham and David J Bloomfield and Charlie Chan and Suzy Cleator and Charlotte E Coles and Ellen Donovan and Helen Fleming and David Glynn and Andrew Goodman and Susan Griffin and Penelope Hopwood and Anna M Kirby and Cliona C Kirwan and Zohal Nabi and Jaymini Patel and Elinor Sawyer and Navita Somaiah and Isabel Syndikus and Karen Venables and John R Yarnold and Judith M Bliss},
year = {2023},
journal = {Health Technology Assessment},
doi = {10.3310/wwbf1044},
url = {https://doi.org/10.3310/wwbf1044}
}RIS
TY - JOUR TI - One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT AU - Adrian Murray Brunt AU - Joanne S Haviland AU - Duncan A Wheatley AU - Mark A Sydenham AU - David J Bloomfield AU - Charlie Chan AU - Suzy Cleator AU - Charlotte E Coles AU - Ellen Donovan AU - Helen Fleming AU - David Glynn AU - Andrew Goodman AU - Susan Griffin AU - Penelope Hopwood AU - Anna M Kirby AU - Cliona C Kirwan AU - Zohal Nabi AU - Jaymini Patel AU - Elinor Sawyer AU - Navita Somaiah AU - Isabel Syndikus AU - Karen Venables AU - John R Yarnold AU - Judith M Bliss PY - 2023 JO - Health Technology Assessment DO - 10.3310/wwbf1044 UR - https://doi.org/10.3310/wwbf1044 ER -
APA
Brunt, A. M., Haviland, J. S., Wheatley, D. A., Sydenham, M. A., Bloomfield, D. J., Chan, C., Cleator, S., Coles, C. E., Donovan, E., Fleming, H., Glynn, D., Goodman, A., Griffin, S., Hopwood, P., Kirby, A. M., Kirwan, C. C., Nabi, Z., Patel, J., Sawyer, E., Somaiah, N., Syndikus, I., Venables, K., Yarnold, J. R., & Bliss, J. M. (2023). One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT. Health Technology Assessment. https://doi.org/10.3310/wwbf1044
Source records
- crossref · retrieved 2026-09-25T00:52:57.676Z